Related references
Note: Only part of the references are listed.Evaluation of Type Replacement Following HPV16/18 Vaccination: Pooled Analysis of Two Randomized Trials
Joseph E. Tota et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2017)
HPV vaccine coverage is increasing in Australia
Julia M. L. Brotherton et al.
MEDICAL JOURNAL OF AUSTRALIA (2017)
Differences between vaccinated and unvaccinated women explain increase in non-vaccine-type human papillomavirus in unvaccinated women after vaccine introduction
Lili Ding et al.
VACCINE (2017)
Timing of two versus three doses of quadrivalent HPV vaccine and associated effectiveness against condyloma in Sweden: a nationwide cohort study
F. Lamb et al.
BMJ OPEN (2017)
Cervical screening with primary HPV testing or cytology in a population of women in which those aged 33 years or younger had previously been offered HPV vaccination: Results of the Compass pilot randomised trial
Karen Canfell et al.
PLOS MEDICINE (2017)
Evaluation of Type Replacement Following HPV16/18 Vaccination: Pooled Analysis of Two Randomized Trials
Joseph E. Tota et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2017)
Comparison of the Roche CobasA® 4800 HPV assay to Roche Amplicor for detection of high-risk human papillomavirus
S. Phillips et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2016)
Immunogenicity and HPV infection after one, two, and three doses of quadrivalent HPV vaccine in girls in India: a multicentre prospective cohort study
Rengaswamy Sankaranarayanan et al.
LANCET ONCOLOGY (2016)
HPV vaccine impact in Australian women: ready for an HPV-based screening program
Julia M. L. Brotherton et al.
MEDICAL JOURNAL OF AUSTRALIA (2016)
Population-level impact, herd immunity, and elimination after human papillomavirus vaccination: a systematic review and meta-analysis of predictions from transmission-dynamic models
Marc Brisson et al.
LANCET PUBLIC HEALTH (2016)
Population-Level Effects of Human Papillomavirus Vaccination Programs on Infections with Nonvaccine Genotypes
David Mesher et al.
EMERGING INFECTIOUS DISEASES (2016)
Human papillomavirus in young women with Chlamydia trachomatis infection 7 years after the Australian human papillomavirus vaccination programme: a cross-sectional study
Eric P. F. Chow et al.
LANCET INFECTIOUS DISEASES (2015)
A 9-Valent HPV Vaccine against Infection and Intraepithelial Neoplasia in Women
E. A. Joura et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Assessing genital human papillomavirus genoprevalence in young Australian women following the introduction of a national vaccination program
Sarah L. Osborne et al.
VACCINE (2015)
Evaluation of Human Papillomavirus Type Replacement Postvaccination Must Account for Diagnostic Artifacts: Masking of HPV52 by HPV16 in Anogenital Specimens
Joseph E. Tota et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2015)
Fall in Genital Warts Diagnoses in the General and Indigenous Australian Population Following Implementation of a National Human Papillomavirus Vaccination Program: Analysis of Routinely Collected National Hospital Data
Megan A. Smith et al.
JOURNAL OF INFECTIOUS DISEASES (2015)
Effectiveness of less than three doses of quadrivalent human papillomavirus vaccine against cervical intraepithelial neoplasia when administered using a standard dose spacing schedule: Observational cohort of young women in Australia
Julia M. L. Brotherton et al.
PAPILLOMAVIRUS RESEARCH (2015)
HPV genotype prevalence in Australian women undergoing routine cervical screening by cytology status prior to implementation of an HPV vaccination program
Sepehr N. Tabrizi et al.
JOURNAL OF CLINICAL VIROLOGY (2014)
Assessment of herd immunity and cross-protection after a human papillomavirus vaccination programme in Australia: a repeat cross-sectional study
Sepehr N. Tabrizi et al.
LANCET INFECTIOUS DISEASES (2014)
Human papillomavirus (HPV) vaccination coverage in young Australian women is higher than previously estimated: Independent estimates from a nationally representative mobile phone survey
Julia M. L. Brotherton et al.
VACCINE (2014)
Effectiveness of quadrivalent human papillomavirus vaccine for the prevention of cervical abnormalities: case-control study nested within a population based screening programme in Australia
Elizabeth Crowe et al.
BMJ-BRITISH MEDICAL JOURNAL (2014)
Impact of a population-based HPV vaccination program on cervical abnormalities: a data linkage study
Dorota M. Gertig et al.
BMC MEDICINE (2013)
Worldwide human papillomavirus genotype attribution in over 2000 cases of intraepithelial and invasive lesions of the vulva
Silvia de Sanjose et al.
EUROPEAN JOURNAL OF CANCER (2013)
Human papillomavirus vaccine coverage among female Australian adolescents: success of the school-based approach
Julia M. L. Brotherton et al.
MEDICAL JOURNAL OF AUSTRALIA (2013)
Genital warts in young Australians five years into national human papillomavirus vaccination programme: national surveillance data
Hammad Ali et al.
BMJ-BRITISH MEDICAL JOURNAL (2013)
Fall in Human Papillomavirus Prevalence Following a National Vaccination Program
Sepehr N. Tabrizi et al.
JOURNAL OF INFECTIOUS DISEASES (2012)
Comparison of the Cobas 4800 Human Papillomavirus test against a combination of the Amplicor Human Papillomavirus and the Linear Array tests for detection of HPV types 16 and 18 in cervical samples
Samuel Bernal Martinez et al.
JOURNAL OF VIROLOGICAL METHODS (2012)
Global Burden of Human Papillomavirus and Related Diseases
David Forman et al.
VACCINE (2012)
Efficacy and Safety of Prophylactic Vaccines against Cervical HPV Infection and Diseases among Women: A Systematic Review & Meta-Analysis
Beibei Lu et al.
BMC INFECTIOUS DISEASES (2011)
Human papillomavirus prevalence among indigenous and non-indigenous Australian women prior to a national HPV vaccination program
Suzanne M. Garland et al.
BMC MEDICINE (2011)
End-of-study safety, immunogenicity, and efficacy of quadrivalent HPV (types 6, 11, 16, 18) recombinant vaccine in adult women 24-45 years of age
X. Castellsague et al.
BRITISH JOURNAL OF CANCER (2011)
Quadrivalent human papillomavirus vaccination and trends in genital warts in Australia: analysis of national sentinel surveillance data
Basil Donovan et al.
LANCET INFECTIOUS DISEASES (2011)
Measuring human papillomavirus (HPV) vaccination coverage and the role of the National HPV Vaccination Program Register, Australia
Dorota M. Gertig et al.
SEXUAL HEALTH (2011)
Evolutionary Dynamics of Variant Genomes of Human Papillomavirus Types 18, 45, and 97
Zigui Chen et al.
JOURNAL OF VIROLOGY (2009)
Development and validation of a real-time PCR assay specifically detecting human papillomavirus 52 using the Roche LightCycler® 480 system
Matthew R. Stevens et al.
JOURNAL OF VIROLOGICAL METHODS (2008)
Assessment of MagNA pure LC extraction system for detection of human papillomavirus (HPV) DNA in PreservCyt samples by the Roche AMPLICOR and LINEAR ARRAY HPV tests
Matthew P. Stevens et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2006)
Evaluation of a modified reverse line blot assay for detection and typing of human papillomavirus
SN Tabrizi et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2005)
A prospective study of age trends in cervical human papillomavirus acquisition and persistence in Guanacaste, Costa Rica
PE Castle et al.
JOURNAL OF INFECTIOUS DISEASES (2005)
Share Paper
